medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2016, Number 4

<< Back Next >>

Acta Pediatr Mex 2016; 37 (4)

CHAMACON: potentially lethal exposures in pediatrics

Bazán-Godínez S, Pérez-Tuñon JG

Language: Spanish
References: 57
Page: 228-240
PDF size: 423.61 Kb.


ABSTRACT

Accidental exposure to potentially toxic substances is a common problem in children. This condition could be catastrophic, depending on factors associated with the patient, their environment and the substance involved. In this sense, there is a group of commonly used substances that when ingested by an infant, even in small amounts (one tablet, sip or spoonful), may cause death, either because they are highly toxic or simply because they are in a high concentration. When a child ingests any of these substances, it should be recognized as “a potentially lethal exposure”. We propose the mnemonics CHAMACON to identify those substances and subsequently, we mentioned key aspects for the initial treatment in this exposures.


REFERENCES

  1. Shannon M. Ingestion of toxic substances by children. N Engl J Med. 2000;(342):186-91.

  2. Mowry JB, Spyker DA, Brooks DE, et al. 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32st Annual Report. Clin Tox. 2015; 53(10):962-1146.

  3. Bryant S, Singer J. Management of toxic exposure in children. Emerg Med Clin N Am. 2003;21:101-19.

  4. Abbruzzi G, Stork CM. Pediatric toxicologic concerns. Emerg Med Clin North Am 2002;(20):223–47.

  5. Hoffman RS, Howland MA, Levin NA, et al. Goldfrank´s Toxicologic emergencies. Mc Graw-Hill. 10a ed. 2015;(32):743-61.

  6. Mintegui S. Manual de intoxicaciones en pediatría. 2ª edición. Ergon. España. 2008(3):55-117.

  7. Liebelt EL, Shannon M. Small doses, big problems: a selected review of highly toxic common medications. Pediatr Emerg Care. 1993;9(5):292-7.

  8. Matteucci M. One pill can kill: assessing the potential for fatal poisonings in children. Pediatr Ann. 2005;(34):964–8.

  9. Bar-Oz B, Levichek Z. Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Paediatr drugs. 2004;6(2):123-6.

  10. Braitberg G, Oakley E. Small dose...big poison. Aust Fam Physician. 2010;39(11):826-33.

  11. Michael JB, Sztajnkrycer. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin North Am. 2004;22(4):1019-50.

  12. White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis. 2007;(7):549-58.

  13. Greene S, Harris C, Singer J. Gastrointestinal Decontamination of the Poisoned Patient. Pediatr Emerg Care. 2008;24(3):176-86.

  14. Albertson TE, Owen KP, Sutter ME. Gastrointestinal decontamination in the acutely poisoned patient. Int J Em Med. 2011;(4): 65.

  15. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology;European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol.1999;(37):731-51.

  16. American Heart Association: 2010 Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation. 2010;(122):S876–S908.

  17. Yanturali S. Diazepam for treatment of massive chloroquine intoxication. Resuscitation. 2004;(63):347-8.

  18. Glatstein M, Garcia-Bournissen F, Scolnik D, et al. Sulfonylurea intoxication at a tertiary care paediatric hospital. Can J Clin Pharmacol. 2010;(17):51–6.

  19. Benson BE, Hoppu K, Troutman WG, et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol. 2013;(51):140-6.

  20. Chyka PA, Seger D, Krenzelok EP, et al. Position paper: single-dose activated charcoal. Clin Toxicol EUA. 2005;(43):61-87.

  21. Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab.1993;(76):752-6.

  22. Belson MG, Gorman SE, Sullivan K, et al. Calcium channel blocker ingestions in children. Am J Emerg Med. 2000;(18):581–6.

  23. Love JN, Sachdeva DK. Are 1 - 2 tablets dangerous? Beta blocker exposure in toddlers. J Emerg Med. 2004;(26):309-14.

  24. DeWitt C, Waksman J. Pharmacology, pathophysiology and management of calcium channel blocker and beta blocker toxicity. Toxicol Rev. 2004;(23):223-38.

  25. St-Onge M, Dubé PA, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila). 2014;52(9):926-44.

  26. American Academy of Clinical Toxicology, European Association of Poison Centers and Clinical Toxicologists. Position Paper: Whole Bowel Irrigation. Clin Toxicol 2004;42(6):843-54.

  27. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf. 2003;(26):65-79.

  28. Broner CW, Stidham GL, Westenkirchner DF, et al. A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies forhypocalcemia in critically ill children. J Pediatr. 1990;(117):986-9.

  29. St-Onge M, Ajmo I, Poirier D, et al. L-Carnitine for the treatment of a calcium channel blocker and metformin poisoning. J Med Toxicol. 2013;9(3):266-9.

  30. Auzépy P, Boukara N, Richard C, et al. Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases. Ann CardiolAngeiol. 1983;32(4):253-8.

  31. Rosenbaum TG, Kou M. Are one or two dangerous? Tricyclic antidepressant exposure in toddlers. J Emerg Med. 2005;(28):169-74.

  32. Shannon MW, Merola J, Lovejoy Jr FH. Hypotension in severe tricyclic antidepressant overdose. Am J Emerg Med. 1988;(6):439-42.

  33. Sholten HA, Nap A, Bouwman RA, et al. Intralipid as an antidote for tricyclic antidepressants and SSARIs: a case report. Anaesth Intensive Care. 2012;(40):1076-7.

  34. Cao D, Heard K, Foran M, et al. Intravenous lipid emulsion in the emergency department: a systematic review of recent literature. J Emerg Med. 2015;48(3):387-97.

  35. Bhanushali MJ, Tuite PJ. The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin. 2004;(22):389-411.

  36. Minns AB, Clark RF. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 2012;(43):906-13.

  37. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986;1(5):309-34.

  38. Sivilotti MLA. Ethanol: tastes great! Fomepizole: less filling! Ann Emerg Med. 2008;(53):451-3.

  39. Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;(40):415-46.

  40. Beatty L,Green R, Magee K, et al. A systematic review of ethanol and fomepizole use in toxic alcohol ingestions. Emerg Med Int. 2013;(2013):1-14.

  41. Brent J. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol and methanol poisonings. Clin Toxicol (Phila). 2010;48(5):401-6.

  42. Roldán J, Frauca C, Dueñas A. Intoxicación por alcoholes. ANALES Sis San Navarra. 2003;26(1):129-39.

  43. Mahieu LM, Rooman RP, Goossens E.Imidazoline intoxication in children. Eur J Pediatr. 1993;152(11):944-6.

  44. Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. J Pediatr (Rio J). 2003;79(6):519-24.

  45. Higgins GL, Campbell B, Wallace K, et al. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med. 1991;20(6):655-8.

  46. Boyer EW. Management of Opioid Analgesic Overdose. N Engl J Med. 2012;367(2):146-55.

  47. McCarron MM, Challoner KR, Thompson GA. Diphenoxylate- atropine (Lomotil) overdose in children: an update (report of eight cases and review of the literature). Pediatrics. 1991;(87):694-700.

  48. Sachdeva DK, Stadnyk JM. Are one or two dangerous? Opioid exposure in toddlers. J Emerg Med 2005;(29):77-84.

  49. Gonzalez JP, Brogden RN. Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;(35):192-213.

  50. American Academy of Pediatrics Committee on Drugs. Camphor revisited: focus on toxicity. Pediatrics. 1994;(94):127-8.

  51. Patra C, Sarkar S, Dasgupta MK, et al. Camphor poisoning: An unusual cause of seizure in children. J Pediatr Neurosci. 2015;10(1):78-9.

  52. Emery D, Corban J. Camphor toxicity. J Paediatr Child Health. 1999;(35):105-6.

  53. Love JN, Sammon M, Smereck J. Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med. 2004;(27):49-54.

  54. Appleton S. Frequency and outcomes of accidental ingestion of tobacco products in young children. Reg Tox Pharmacol. 2011;(61):210-4.

  55. Bonadio WA, Anderson Y. Tobacco ingestions in children. Clin Pediatr. 1989;(28):592-3.

  56. Connolly GN, Richter P, Aleguas A, et al. Unintentional child poisonings through ingestion of conventional and novel tobacco products. Pediatrics. 2010;(125):896-9.

  57. Centro para el Control del Envenenamiento de la Ciudad de Nueva York. Publicaciones: Usted puede proteger su casa contra venenos. En: http://poisoncontrol.vanguarddirect. com/es. Acceso 06 de enero de 2016.




2020     |     www.medigraphic.com